Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor

Haibiao Gong, Ping Guo, Yonggong Zhai, Jie Zhou, Hirdesh Uppal, Michael J. Jarzynka, Wen Chao Song, Shi Yuan Cheng, Wen Xie

Research output: Contribution to journalArticle

  • 76 Citations

Abstract

Estrogen plays an important role in normal physiology. It is also a risk factor for breast cancer, and antiestrogen therapies have been shown to be effective in the treatment and prevention of breast cancers. The liver is important for estrogen metabolism, and a compromised liver function has been linked to hyperestrogenism in patients. In this report, we showed that the liver X receptor (LXR) controls estrogen homeostasis by regulating the basal and inducible hepatic expression of estrogen sulfotransferase (Est, or Sult1e1), an enzyme critical for metabolic estrogen deactivation. Genetic or pharmacological activation of LXR resulted in Est induction, which in turn inhibited estrogen-dependent uterine epithelial cell proliferation and gene expression, as well as breast cancer growth in a nude mouse model of tumorigenicity. We further established that Est is a transcriptional target of LXR, and deletion of the Est gene in mice abolished the LXR effect on estrogen deprivation. Interestingly, Est regulation by LXR appeared to be liver specific, further underscoring the role of liver in estrogen metabolism. Activation of LXR failed to induce other major estrogen-metabolizing enzymes, suggesting that the LXR effect on estrogen metabolism is Est specific. In summary, our results have revealed a novel mechanism controlling estrogen homeostasis in vivo and may have implications for drug development in the treatment of breast cancer and other estrogen-related cancerous endocrine disorders.

LanguageEnglish (US)
Pages1781-1790
Number of pages10
JournalMolecular Endocrinology
Volume21
Issue number8
DOIs
StatePublished - Aug 3 2007

Fingerprint

Orphan Nuclear Receptors
Estrogens
Breast Neoplasms
Growth
Liver
Homeostasis
Liver X Receptors
Estrogen Receptor Modulators
Gene Deletion
Enzymes
Nude Mice
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Gong, Haibiao ; Guo, Ping ; Zhai, Yonggong ; Zhou, Jie ; Uppal, Hirdesh ; Jarzynka, Michael J. ; Song, Wen Chao ; Cheng, Shi Yuan ; Xie, Wen. / Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. In: Molecular Endocrinology. 2007 ; Vol. 21, No. 8. pp. 1781-1790.
@article{b221cc13040745d1b31dd63b3f487318,
title = "Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor",
abstract = "Estrogen plays an important role in normal physiology. It is also a risk factor for breast cancer, and antiestrogen therapies have been shown to be effective in the treatment and prevention of breast cancers. The liver is important for estrogen metabolism, and a compromised liver function has been linked to hyperestrogenism in patients. In this report, we showed that the liver X receptor (LXR) controls estrogen homeostasis by regulating the basal and inducible hepatic expression of estrogen sulfotransferase (Est, or Sult1e1), an enzyme critical for metabolic estrogen deactivation. Genetic or pharmacological activation of LXR resulted in Est induction, which in turn inhibited estrogen-dependent uterine epithelial cell proliferation and gene expression, as well as breast cancer growth in a nude mouse model of tumorigenicity. We further established that Est is a transcriptional target of LXR, and deletion of the Est gene in mice abolished the LXR effect on estrogen deprivation. Interestingly, Est regulation by LXR appeared to be liver specific, further underscoring the role of liver in estrogen metabolism. Activation of LXR failed to induce other major estrogen-metabolizing enzymes, suggesting that the LXR effect on estrogen metabolism is Est specific. In summary, our results have revealed a novel mechanism controlling estrogen homeostasis in vivo and may have implications for drug development in the treatment of breast cancer and other estrogen-related cancerous endocrine disorders.",
author = "Haibiao Gong and Ping Guo and Yonggong Zhai and Jie Zhou and Hirdesh Uppal and Jarzynka, {Michael J.} and Song, {Wen Chao} and Cheng, {Shi Yuan} and Wen Xie",
year = "2007",
month = "8",
day = "3",
doi = "10.1210/me.2007-0187",
language = "English (US)",
volume = "21",
pages = "1781--1790",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "8",

}

Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. / Gong, Haibiao; Guo, Ping; Zhai, Yonggong; Zhou, Jie; Uppal, Hirdesh; Jarzynka, Michael J.; Song, Wen Chao; Cheng, Shi Yuan; Xie, Wen.

In: Molecular Endocrinology, Vol. 21, No. 8, 03.08.2007, p. 1781-1790.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor

AU - Gong, Haibiao

AU - Guo, Ping

AU - Zhai, Yonggong

AU - Zhou, Jie

AU - Uppal, Hirdesh

AU - Jarzynka, Michael J.

AU - Song, Wen Chao

AU - Cheng, Shi Yuan

AU - Xie, Wen

PY - 2007/8/3

Y1 - 2007/8/3

N2 - Estrogen plays an important role in normal physiology. It is also a risk factor for breast cancer, and antiestrogen therapies have been shown to be effective in the treatment and prevention of breast cancers. The liver is important for estrogen metabolism, and a compromised liver function has been linked to hyperestrogenism in patients. In this report, we showed that the liver X receptor (LXR) controls estrogen homeostasis by regulating the basal and inducible hepatic expression of estrogen sulfotransferase (Est, or Sult1e1), an enzyme critical for metabolic estrogen deactivation. Genetic or pharmacological activation of LXR resulted in Est induction, which in turn inhibited estrogen-dependent uterine epithelial cell proliferation and gene expression, as well as breast cancer growth in a nude mouse model of tumorigenicity. We further established that Est is a transcriptional target of LXR, and deletion of the Est gene in mice abolished the LXR effect on estrogen deprivation. Interestingly, Est regulation by LXR appeared to be liver specific, further underscoring the role of liver in estrogen metabolism. Activation of LXR failed to induce other major estrogen-metabolizing enzymes, suggesting that the LXR effect on estrogen metabolism is Est specific. In summary, our results have revealed a novel mechanism controlling estrogen homeostasis in vivo and may have implications for drug development in the treatment of breast cancer and other estrogen-related cancerous endocrine disorders.

AB - Estrogen plays an important role in normal physiology. It is also a risk factor for breast cancer, and antiestrogen therapies have been shown to be effective in the treatment and prevention of breast cancers. The liver is important for estrogen metabolism, and a compromised liver function has been linked to hyperestrogenism in patients. In this report, we showed that the liver X receptor (LXR) controls estrogen homeostasis by regulating the basal and inducible hepatic expression of estrogen sulfotransferase (Est, or Sult1e1), an enzyme critical for metabolic estrogen deactivation. Genetic or pharmacological activation of LXR resulted in Est induction, which in turn inhibited estrogen-dependent uterine epithelial cell proliferation and gene expression, as well as breast cancer growth in a nude mouse model of tumorigenicity. We further established that Est is a transcriptional target of LXR, and deletion of the Est gene in mice abolished the LXR effect on estrogen deprivation. Interestingly, Est regulation by LXR appeared to be liver specific, further underscoring the role of liver in estrogen metabolism. Activation of LXR failed to induce other major estrogen-metabolizing enzymes, suggesting that the LXR effect on estrogen metabolism is Est specific. In summary, our results have revealed a novel mechanism controlling estrogen homeostasis in vivo and may have implications for drug development in the treatment of breast cancer and other estrogen-related cancerous endocrine disorders.

UR - http://www.scopus.com/inward/record.url?scp=34547475143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547475143&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0187

DO - 10.1210/me.2007-0187

M3 - Article

VL - 21

SP - 1781

EP - 1790

JO - Molecular Endocrinology

T2 - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 8

ER -